CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Orchestra Biomed Fiscal Q4 2023 Earnings Report | CapyFin

Orchestra Biomed

OBIO · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 in 4d Q3 2025 +4.58%Q2 2025 -2.57%Q1 2025 +0.35%Q4 2024 -6.04%Q3 2024 -0.98%Q2 2024 -3.72%Q1 2024 +10.40%Q4 2023 +0.19%Q3 2023 +29.60%Q2 2023 +5.29%Q1 2023 +2.53%Q4 2022 +30.49%Q3 2022 +0.30%Q2 2022 0.00%Q1 2022 0.00%Q4 2021 0.00%Q1 2021 +3.69%

Mar 27, 2024

•

Dec 31, 2023

Orchestra Biomed Q4 2023 Earnings Report

Previous year: -$0.07

Selling, general and administrative expenses

Interest income, net

Stock-based compensation

Previous year: $1.05M

Cash and Equivalents

Previous year: $19.8M

Previous year: -$614K

Previous year: $95.6M

Orchestra Biomed

Unlock previous datapoints

Orchestra Biomed

Unlock previous datapoints

Revenue by Segment

Partnership Revenue

CapyFin.com

Product Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Orchestra Biomed

Orchestra Biomed Revenue by Segment